Member of EuDRAcon

We are proud to be a member of EuDRAcon: the pan-European network of regulatory affairs consultancy companies in the pharma field. In order to achieve the most effective resolution of all regulatory matters, we have chosen to conduct business in a network of selected nationally based companies in almost all of the member states of […]

18th EuDRAcon Conference

Yesterday Mericon hosted the 18th EuDRAcon Conference, and even if this conference was postponed one year and was held as a digital version, we managed to gather a total of 43 participants from 24 of our European member companies. Regulatory affairs topics from the Norwegian perspective were elucidated by speakers from The Norwegian Medicines Agency […]

New COB in Mericon AS

At the annual general meeting on 28/4-2021 Bjørn Fuglaas was elected as the new Chairman of the Board. Bjørn is currently a partner in Gevirgroup AS, and has long experience within life science and pharmaceutical industry in Norway. His background includes previous senior positions in GE Healthcare, Amersham Health and Nycomed. He has also held several […]

Grenland is ready for more drug industry

The mayors in the Grenland Region in Norway have responded to The Norwegian Directorate of Health on a report related to the National Preparedness for Medicinal Products.  The goal of the mayors is to attract new enterprises related to the pharmaceutical industry and support already established pharmaceutical industry in the Grenland Region. Currently there are […]

Product information – the importance of high quality translations

The Norwegian medicines agency (NoMA) strongly encourage the marketing authorisation holders (MAH) to focus on high quality translations of the product information (PI). Mericons experienced consultants can help you with high quality translations, both in PI’s and other medicinal and pharmaceutical documents. Feel free to contact us if you are interested in our services, or take […]

Dear client

The coronavirus disease (COVID-19) outbreak causes operational and organisational challenges which we will need to solve for our company. This may impact you and your business. We would therefore like to inform you on how we are planning to meet these challenges during the disease outbreak. We are available In Mericon we have now implemented […]

Grenland makes an effort towards building up Drug Industry in the region

Vekst I Grenland (Invest in Grenland, ViG) has in collaboration with Skien municipality, Kragerø municipality, Vekst I Grenland and the project Helseinnovasjon (Health Innovation) Telemark initiated a project with the goal of attracting new enterprises related to the pharmaceutical industry and support already established pharmaceutical industry in the Grenland region.  Wednesday LMI (the Norwegian Drug […]

Need of medicinal products in Norway

The Norwegian Medicines Agency has recently announced a need for more suppliers or alternatives on the market in Norway for the active substances glyceryl trinitrate, ivermectin, erythromycin and Ferrous (II) Glycine Sulphate Complex , and want to get in contact with possible suppliers. The Norwegian Medicines Agency’s announcement list are applicable for medicinal products deemed […]

M. Sc. Pharm, GDP/Reg. Affairs

Mericon is expanding and is looking for a new consultant within GDP/Regulatory Affairs. If you have a master’s degree in pharmacy and are looking for an exiting position in a small, but prestigious company, please contact us. Information about the position and application form can be found at Contact person in Mericon is Nils-Ragnar […]